Application Nr Approved Date Route Status External Links
ANDA202045 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Duloxetine Delayed-Release Capsules Are Indicated For The Treatment Of: 1. Major Depressive Disorder [See Clinical Studies ( 14.1 )] 2. Generalized Anxiety Disorder [See Clinical Studies ( 14.2 )] 3. Diabetic Peripheral Neuropathy [See Clinical Studies ( 14.3 )] 4. Chronic Musculoskeletal Pain [See Clinical Studies ( 14.5 )] Duloxetine Delayed-Release Capsules Are A Serotonin And Norepinephrine Reuptake Inhibitor (Snri) Indicated For: 5. Major Depressive Disorder (Mdd) ( 1 ) 6. Generalized Anxiety Disorder (Gad) ( 1 ) 7. Diabetic Peripheral Neuropathic Pain (Dpnp) ( 1 ) 8. Chronic Musculoskeletal Pain ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Duloxetine Hydrochloride DULOXETINE HYDROCHLORIDE ZINC1536779

Comments